Conatus CFO Charles J. Cashion to resign
Mr. Cashion is one of company's co-founders and has served as Senior Vice President, Finance, Chief Financial Officer, and Secretary since July 2005.
From 2001 to 2005, Mr. Cashion was Chief Financial Officer at Idun Pharmaceuticals, Inc., a privately-owned biopharmaceutical company.
Mr. Cashion has held several senior level management positions in both private and public healthcare companies with responsibilities for securing and executing various types of financings including initial public offerings, secondary offerings, corporate partnerships, and debt.
Mr. Cashion joined Idun Pharmaceuticals in 2001 as Executive Vice President, Chief Financial Officer and Secretary.
Previously, he held the position of Senior Vice President and Chief Financial Officer of Quidel Corporation, a publicly-held medical diagnostics company.
For the prior nine years, Mr. Cashion was Senior Vice President, Finance, and Chief Financial Officer of The Immune Response Corporation, a publicly-held biopharmaceutical company.
During the period from 1980 to 1989, he was Executive Vice President and Chief Financial Officer of Smith Laboratories, Inc., a publicly-held pharmaceutical company and during 1987 through 1989 was also President and Chief Executive Officer of Sutter Corporation, an orthopedic products subsidiary of Smith Laboratories.
Mr. Cashion also held positions at Baxter International, Inc. and Motorola, Inc.
Mr. Cashion holds an M.B.A. and B.S. in Accounting from Northern Illinois University. ■
What to read next
LATEST MOVES FROM California
- Peregrine Pharmaceuticals appoints Mark R. Bamforth to boards
- Endologix appoints John Onopchenko as COO
- Depomed appoints Santosh J. Vetticaden as CSO
- Wells Fargo names Michael Roemer as chief compliance officer
- ARMO BioSciences appoints Joseph Leveque as CMO
More inside POST
Oracle posts 14% gain in Q1 earnings Earnings
Foot Locker Q2 income falls 36% Earnings